From Research to Use: Saving Newborn Lives With Chlorhexidine for Umbilical Cord Care
PATH just released a report entitled From Research to Use: Saving Newborn Lives With Chlorhexidine for Umbilical Cord Care
Roughly 2.76 million newborns die globally each year, and infections cause at least 15% of those deaths. Optimal cord care at birth and in the first week of life, especially in settings with poor hygiene, is critical to averting neonatal deaths.
Chlorhexidine digluconate’s novel formulation for umbilical cord care, 7.1% chlorhexidine digluconate (CHX), has a higher concentration of active ingredient than other currently marketed products and can prevent cord infection and neonatal sepsis.
Over the past decade, CHX has moved rapidly from initial concept to a global health success. Today, CHX is implemented as part of the package of essential newborn interventions in more than ten countries in South Asia and sub-Saharan Africa and will save many newborn lives in the years to come.
The story of chlorhexidine is a story of a product’s journey from evidence building to policy development, production, and demand generation—and eventually to adoption and scale-up. It is also the story of the many groups and individuals who have committed to identifying and scaling an effective, appropriate intervention to improve newborn health and protect babies from preventable illnesses. This report showcases the scope and breadth of the work of these groups.